SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $9,430,000 | +20.1% | 629,541 | -2.4% | 0.00% | 0.0% |
| Q1 2016 | $7,849,000 | -29.4% | 645,026 | -7.7% | 0.00% | -33.3% |
| Q4 2015 | $11,119,000 | +5.3% | 698,894 | +1.5% | 0.00% | 0.0% |
| Q3 2015 | $10,555,000 | -37.7% | 688,529 | -1.1% | 0.00% | -25.0% |
| Q2 2015 | $16,929,000 | +0.8% | 696,362 | -3.6% | 0.00% | 0.0% |
| Q1 2015 | $16,794,000 | -9.9% | 722,325 | -2.7% | 0.00% | 0.0% |
| Q4 2014 | $18,649,000 | -10.3% | 742,690 | +11.1% | 0.00% | -20.0% |
| Q3 2014 | $20,788,000 | +19.1% | 668,438 | -1.0% | 0.01% | +25.0% |
| Q2 2014 | $17,455,000 | +3.9% | 675,006 | -6.1% | 0.00% | -20.0% |
| Q1 2014 | $16,804,000 | -5.1% | 719,029 | +3.1% | 0.01% | 0.0% |
| Q4 2013 | $17,703,000 | -14.6% | 697,522 | -31.4% | 0.01% | -16.7% |
| Q3 2013 | $20,729,000 | -4.9% | 1,016,143 | -2.2% | 0.01% | -14.3% |
| Q2 2013 | $21,791,000 | – | 1,038,653 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |